AI Classification
InconclusiveFine-tuned Classification
N/APalmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial
Recurrent Severe Burns Due to Cannabinoid Hyperemesis Syndrome
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)
Alteration of faecal microbiota balance related to long-term deep meditation
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
The effects of collagen peptides on exercise-induced gastrointestinal stress: a randomized, controlled trial